Biomedical Sciences Research Complex, School of Biology, University of St Andrews, Fife KY16 9ST, UK.
Appl Microbiol Biotechnol. 2010 Feb;85(6):1629-42. doi: 10.1007/s00253-009-2355-3. Epub 2009 Dec 3.
Amongst the diverse and potent biological activities of free fatty acids (FFAs) is the ability to kill or inhibit the growth of bacteria. The antibacterial properties of FFAs are used by many organisms to defend against parasitic or pathogenic bacteria. Whilst their antibacterial mode of action is still poorly understood, the prime target of FFA action is the cell membrane, where FFAs disrupt the electron transport chain and oxidative phosphorylation. Besides interfering with cellular energy production, FFA action may also result from the inhibition of enzyme activity, impairment of nutrient uptake, generation of peroxidation and auto-oxidation degradation products or direct lysis of bacterial cells. Their broad spectrum of activity, non-specific mode of action and safety makes them attractive as antibacterial agents for various applications in medicine, agriculture and food preservation, especially where the use of conventional antibiotics is undesirable or prohibited. Moreover, the evolution of inducible FFA-resistant phenotypes is less problematic than with conventional antibiotics. The potential for commercial or biomedical exploitation of antibacterial FFAs, especially for those from natural sources, is discussed.
游离脂肪酸 (FFAs) 具有多种生物活性,其中包括杀菌或抑制细菌生长的能力。FFAs 的抗菌特性被许多生物用来抵御寄生虫或病原菌。尽管它们的抗菌作用机制仍不清楚,但 FFA 的主要作用靶点是细胞膜,FFAs 会破坏电子传递链和氧化磷酸化。除了干扰细胞能量产生外,FFA 的作用还可能源于对酶活性的抑制、营养物质摄取的损害、过氧化和自动氧化降解产物的产生,或者直接裂解细菌细胞。FFAs 具有广谱的活性、非特异性的作用模式和安全性,使其成为医学、农业和食品保存等领域中各种应用的有吸引力的抗菌剂,特别是在不希望或禁止使用传统抗生素的情况下。此外,与传统抗生素相比,诱导型 FFA 耐药表型的进化问题较少。本文讨论了从商业或生物医学角度开发抗菌 FFAs 的潜力,特别是那些来自天然来源的 FFAs。